Loading clinical trials...
Loading clinical trials...
A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients ≥65 Years of Age Not Eligible for Intensive Chemotherapy
Conditions
Interventions
Eltrombopag
Placebo
Locations
15
Germany
Uniklinik RWTH Aachen
Aachen, Germany
Charite Campus Benjamin Franklin
Berlin, Germany
Klinikum Chemnitz GmbH
Chemnitz, Germany
Universitätsklinikum Dresden
Dresden, Germany
Marienhospital Düsseldorf GmbH
Düsseldorf, Germany
Universitätsklinikum Essen
Essen, Germany
Start Date
May 1, 2015
Primary Completion Date
December 26, 2020
Completion Date
January 25, 2023
Last Updated
March 29, 2024
NCT06285890
NCT06220162
NCT04065399
NCT06484062
NCT04628026
NCT06994676
Lead Sponsor
Technische Universität Dresden
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions